TY - JOUR
T1 - Strategy for diagnosing breast cancer in Indonesia during the COVID-19 pandemic
T2 - Switching to ultrasound-guided percutaneous core needle biopsy
AU - Sobri, Farida Briani
AU - Bachtiar, Adang
AU - Panigoro, Sonar Soni
AU - Rahmaania, Juwita Cresti
AU - Yuswar, Patria Wardana
AU - Krisnuhoni, Ening
AU - Tandiari, Nelly
N1 - Publisher Copyright:
Copyright © 2021, Kesmas: Jurnal Kesehatan Masyarakat Nasional (National Public Health Journal).
PY - 2021/8
Y1 - 2021/8
N2 - In this era of COVID-19, suspected breast cancer patients experience delay in diagnosis due to the fear of contracting the virus and reduction of non-COVID-19 health services. Furthermore, it may lead to potential increase in the incidence of advanced cancers in the future. Ultrasound-guided (US-guided) percutaneous core needle biopsy (CNB) is a great option for the diagnosis of cancer but it is poorly utilized. This study aimed to prove that the US-guided CNB is accurate when performed in a local setting and a potential solution for diagnosing breast cancer patients in this pandemic. In addition, it was a single health center cross-sectional study, and the participants were all breast cancer patients that had US-guided CNB from 2013-2019. The pathology results from US-guided CNB were compared to specimens from post-CNB surgeries. The data were collected from medical records and the immunohistochemistry (IHC) examinations were carried out for malignancy. There were 163 patients who were included in this study, 86 had malignancies and 77 had benign tumor reported in their CNB results. The US-guided CNB had 100% sensitivity and specificity compared to surgery. With its lower cost, time usage, and patient exposure to the hospital environment, US-guided CNB should replace open surgery biopsy for diagnosing suspicious breast cancers during the pandemic in Indonesia.
AB - In this era of COVID-19, suspected breast cancer patients experience delay in diagnosis due to the fear of contracting the virus and reduction of non-COVID-19 health services. Furthermore, it may lead to potential increase in the incidence of advanced cancers in the future. Ultrasound-guided (US-guided) percutaneous core needle biopsy (CNB) is a great option for the diagnosis of cancer but it is poorly utilized. This study aimed to prove that the US-guided CNB is accurate when performed in a local setting and a potential solution for diagnosing breast cancer patients in this pandemic. In addition, it was a single health center cross-sectional study, and the participants were all breast cancer patients that had US-guided CNB from 2013-2019. The pathology results from US-guided CNB were compared to specimens from post-CNB surgeries. The data were collected from medical records and the immunohistochemistry (IHC) examinations were carried out for malignancy. There were 163 patients who were included in this study, 86 had malignancies and 77 had benign tumor reported in their CNB results. The US-guided CNB had 100% sensitivity and specificity compared to surgery. With its lower cost, time usage, and patient exposure to the hospital environment, US-guided CNB should replace open surgery biopsy for diagnosing suspicious breast cancers during the pandemic in Indonesia.
KW - Breast cancer
KW - Core needle biopsy
KW - COVID-19
KW - Health cost
KW - Resources
UR - http://www.scopus.com/inward/record.url?scp=85114650507&partnerID=8YFLogxK
U2 - 10.21109/kesmas.v16i3.4359
DO - 10.21109/kesmas.v16i3.4359
M3 - Article
AN - SCOPUS:85114650507
SN - 1907-7505
VL - 16
SP - 151
EP - 157
JO - Kesmas
JF - Kesmas
IS - 3
ER -